scholarly journals Identification of cellular proteins interacting with PEDV M protein through APEX2 labeling

2021 ◽  
pp. 104191
Author(s):  
Shijuan Dong ◽  
Ruiyang Wang ◽  
Ruisong Yu ◽  
Bingqing Chen ◽  
Fusheng Si ◽  
...  
Keyword(s):  
1999 ◽  
Vol 73 (4) ◽  
pp. 2921-2929 ◽  
Author(s):  
Ronald N. Harty ◽  
Jason Paragas ◽  
Marius Sudol ◽  
Peter Palese

ABSTRACT The matrix (M) protein of rhabdoviruses has been shown to play a key role in virus assembly and budding; however, the precise mechanism by which M mediates these processes remains unclear. We have associated a highly conserved, proline-rich motif (PPxY or PY motif, where P denotes proline, Y represents tyrosine, and x denotes any amino acid) of rhabdoviral M proteins with a possible role in budding mediated by the M protein. Point mutations that disrupt the PY motif of the M protein of vesicular stomatitis virus (VSV) have no obvious effect on membrane localization of M but instead lead to a decrease in the amount of M protein released from cells in a functional budding assay. Interestingly, the PPxY sequence within rhabdoviral M proteins is identical to that of the ligand which interacts with WW domains of cellular proteins. Indeed, results from two in vitro binding assays demonstrate that amino acids 17 through 33 and 29 through 44, which contain the PY motifs of VSV and rabies virus M proteins, respectively, mediate interactions with WW domains of specific cellular proteins. Point mutations that disrupt the consensus PY motif of VSV or rabies virus M protein result in a significant decrease in their ability to interact with the WW domains. These properties of the PY motif of rhabdovirus M proteins are strikingly analogous to those of the late (L) budding domain identified in the gag-specific protein p2b of Rous sarcoma virus. Thus, it is possible that rhabdoviruses may usurp host proteins to facilitate the budding process and that late stages in the budding process of rhabdoviruses and retroviruses may have features in common.


2004 ◽  
Vol 61 (2) ◽  
pp. 161-167
Author(s):  
Hess ◽  
Heijnen

Eine monoklonale Gammopathie ist charakterisiert durch eine übermäßige Produktion von monoklonalem Immunglobulin (M-Protein) und ist die Folge einer klonalen Proliferation von differenzierten B-Lymphozyten oder Plasmazellen. Ein M-Protein kann bei verschiedenen Krankheitsbildern oder als Zustand ohne Krankheitswert vorkommen, und wird mittels Proteinelektrophorese und Immunfixation im Serum und/oder Urin nachgewiesen. Beim Plasmazell-Myelom als häufigster mit einem M-Protein einhergehenden malignen Krankheit sind in den letzten Jahren wesentliche Fortschritte bei der Behandlung erzielt worden. Die autologe Stammzell-Transplantation führt im Vergleich zur konventionellen Chemotherapie nicht nur zu verbesserten Remissionsraten, sondern auch zu einer Verlängerung der Überlebenszeit und gehört heute zur Standardtherapie bei unter 65-jährigen Patienten. Fortschritte in der supportiven Therapie sowie vielversprechende neue Medikamente wie Proteasomen-Inhibitoren und Thalidomid-Analoga dürften die Situation der Betroffenen künftig deutlich verbessern.


Author(s):  
Martin Reynders ◽  
Bryan Matsuura ◽  
Marleen Bérouti ◽  
Daniele Simoneschi ◽  
Antonio Marzio ◽  
...  

<p><i>PROTACs (proteolysis targeting chimeras) are bifunctional molecules that tag proteins for ubiquitylation by an E3 ligase complex and subsequent degradation by the proteasome. They have emerged as powerful tools to control the levels of specific cellular proteins and are on the verge of being clinically used. We now introduce photoswitchable PROTACs that can be activated with the temporal and spatial precision that light provides. These trifunctional molecules, which we named PHOTACs, consist of a ligand for an E3 ligase, a photoswitch, and a ligand for a protein of interest. We demonstrate this concept by using PHOTACs that target either BET family proteins (BRD2,3,4) or FKBP12. Our lead compounds display little or no activity in the dark but can be reversibly activated to varying degrees with different wavelengths of light. Our modular and generalizable approach provides a method for the optical control of protein levels with photopharmacology and could lead to new types of precision therapeutics that avoid undesired systemic toxicity.</i><b></b></p>


2013 ◽  
Vol 32 (4) ◽  
pp. 552-565 ◽  
Author(s):  
James A Nathan ◽  
Hyoung Tae Kim ◽  
Lily Ting ◽  
Steven P Gygi ◽  
Alfred L Goldberg

2021 ◽  
Vol 245 ◽  
pp. 104281
Author(s):  
Liu Chen ◽  
Zheng Ni ◽  
Jionggang Hua ◽  
Weicheng Ye ◽  
Keshu Liu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document